Logo
x

Search

Subscribe Now

Co-develop

Gilead Signs a Ten Years Agreement with Arcus to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies

Gilead Signs a Ten Years Agreement with Arcus to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies

  • May 28, 2020
Innovent Biologics and MD Anderson Collaborate to Co-develop TYVYT (sintilimab) in Rare Cancer Indications in the US

Innovent Biologics and MD Anderson Collaborate to Co-develop TYVYT (sintilimab) in Rare Cancer Indications in the US

  • May 19, 2020
Lilly and Junshi Collaborate to Co-Develop Antibody Therapies for the Treatment of COVID-19

Lilly and Junshi Collaborate to Co-Develop Antibody Therapies for the Treatment of COVID-19

  • May 5, 2020
Pfizer and BioNTech Collaborate to Co-Develop BNT162 Against COVID-19

Pfizer and BioNTech Collaborate to Co-Develop BNT162 Against COVID-19

  • March 17, 2020
AbCellera and Eli Lilly Collaborate to Co-develop Antibody Therapies Targeting COVID-19

AbCellera and Eli Lilly Collaborate to Co-develop Antibody Therapies Targeting COVID-19

  • March 13, 2020
Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications

Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications

  • March 12, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.